Psorinum is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Scabies Lesion Lysate (human).
Product ID | 44911-0097_0e27dae5-db51-4f1a-b12c-c3d8b3576a11 |
NDC | 44911-0097 |
Product Type | Human Prescription Drug |
Proprietary Name | Psorinum |
Generic Name | Psorinum |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2014-12-09 |
Marketing End Date | 2025-09-22 |
Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
Labeler Name | Energique, Inc. |
Substance Name | SCABIES LESION LYSATE (HUMAN) |
Active Ingredient Strength | 7 [hp_X]/mL |
NDC Exclude Flag | N |
Marketing Start Date | 2014-12-09 |
Marketing End Date | 2025-09-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-12-09 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
SCABIES LESION LYSATE (HUMAN) | 7 [hp_X]/mL |
SPL SET ID: | fe712217-e56d-49f7-a791-0351f5e61896 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0220-7604 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
0220-7622 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
0220-7623 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
0220-7624 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
0220-7625 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
0220-7626 | Psorinum | SCABIES LESION LYSATE (HUMAN) |
44911-0097 | Psorinum | Psorinum |
62106-6903 | PSORINUM | Psorinum |
64117-407 | PSORINUM | SCABIES LESION LYSATE (HUMAN) |
69152-1204 | Psorinum 1M | Psorinum |
69152-1006 | Psorinum 200C | Psorinum |